Evidence map›Paper›PMID 35185333›Full record

ArticleBreast cancer : basic and clinical research2022

Anastasia S Proskurina, Victoria V Kupina, Yaroslav R Efremov, Evgenia V Dolgova, Vera S Ruzanova, Genrikh S Ritter, Ekaterina A Potter, Svetlana S Kirikovich, Evgeniy V Levites, Alexandr A Ostanin and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer : basic and clinical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Anastasia S ProskurinaInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Victoria V KupinaNovosibirsk National Research State University, Novosibirsk, Russia.
Yaroslav R EfremovInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Evgenia V DolgovaInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Vera S RuzanovaInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Genrikh S RitterInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Ekaterina A PotterInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Svetlana S KirikovichInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Evgeniy V LevitesInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Alexandr A OstaninResearch Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia.
Elena R ChernykhResearch Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia.
Oksana G BabaevaOncology Department, Municipal Hospital No 1, Novosibirsk, Russia.
Sergey V SidorovNovosibirsk National Research State University, Novosibirsk, Russia.
Sergey S BogachevInstitute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.ORCID https://orcid.org/0000-0002-2019-9382
Institute of Cytology and Genetics · RUNovosibirsk State University · RUResearch Institute of Fundamental and Clinical Immunology · RUCity Clinical Hospital No. 2 · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsBreast tumor specimens were obtained from patients, and basic tumor properties essential for conducting

resultsWe report the first use of

conclusionsThe results of the treatment conducted indicate that

Indexed as

complex composite double-stranded DNA preparationcyclophosphamidemitomycin Сprimary breast cancer cell linesTumor-initiating stem cells

Identifiers

PMID35185333
PMCPMC8851498
OpenAlexW4213338767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.